CSat Investment Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $17K | Buy |
35
+10
| +40% | +$4.86K | 0.01% | 404 |
|
|
2020
Q4 | $12K | Sell |
25
-618
| -96% | -$297K | 0.01% | 416 |
|
|
2020
Q3 | $360K | Buy |
643
+83
| +15% | +$46.5K | 0.03% | 201 |
|
|
2020
Q2 | $349K | Buy |
560
+19
| +4% | +$11.8K | 0.04% | 214 |
|
|
2020
Q1 | $264K | Buy |
541
+139
| +35% | +$67.8K | 0.06% | 208 |
|
|
2019
Q4 | $151K | Buy |
402
+68
| +20% | +$25.5K | 0.04% | 271 |
|
|
2019
Q3 | $93K | Buy |
334
+39
| +13% | +$10.9K | 0.03% | 333 |
|
|
2019
Q2 | $92K | Buy |
295
+273
| +1,241% | +$85.1K | 0.03% | 308 |
|
|
2019
Q1 | $9K | Buy |
22
+2
| +10% | +$818 | ﹤0.01% | 446 |
|
|
2018
Q4 | $7K | Buy |
20
+3
| +18% | +$1.05K | ﹤0.01% | 459 |
|
|
2018
Q3 | $7K | Sell |
17
-7
| -29% | -$2.88K | ﹤0.01% | 431 |
|
|
2018
Q2 | $8K | Buy |
+24
| New | +$8K | ﹤0.01% | 396 |
|